Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 3/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.32 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.32 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.32 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939867 | 0.78 | ALDH1A1 (0.48) | ALDH1A1PKMAPAF1LMNAPOLB | |
| SCHEMBL24939866 | 0.77 | APAF1 (0.31) | ALDH1A1PKMMAPTAPAF1LMNA | |
| SCHEMBL24939865 | 0.76 | LMNA (0.39) | MAPTLMNA | |
| SCHEMBL15977327 | 0.69 | ALDH1A1 (0.41) | ALDH1A1PKMMAPTLMNAPOLB | |
| SCHEMBL7462959 | 0.67 | ALDH1A1 (0.61) | ALDH1A1PKMMAPTLMNAPOLB | |
| SCHEMBL14377608 | 0.67 | ALDH1A1 (0.41) | ALDH1A1PKMMAPTLMNAPOLB | |
| SCHEMBL21911826 | 0.65 | GAA (0.41) | ALDH1A1PKMMAPT | |
| SCHEMBL8892091 | 0.64 | ALDH1A1 (1.00) | ALDH1A1PKMPTGS2LMNAPOLB | |
| SCHEMBL5663770 | 0.64 | ALDH1A1 (0.38) | ALDH1A1PKMLMNA | |
| SCHEMBL17853989 | 0.63 | ALDH1A1 (0.45) | ALDH1A1PKMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | ALDH1A1 3757/4885PKM 3080/4885MAPT 2848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.